Ke Ming

1.8k total citations
61 papers, 1.4k citations indexed

About

Ke Ming is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Ke Ming has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 11 papers in Epidemiology. Recurrent topics in Ke Ming's work include Viral Infections and Immunology Research (11 papers), Animal Virus Infections Studies (9 papers) and Gastrointestinal motility and disorders (6 papers). Ke Ming is often cited by papers focused on Viral Infections and Immunology Research (11 papers), Animal Virus Infections Studies (9 papers) and Gastrointestinal motility and disorders (6 papers). Ke Ming collaborates with scholars based in China and United States. Ke Ming's co-authors include Jiaguo Liu, Yun Chen, Deyun Wang, Fangke Yao, Yuanliang Hu, Hongxu Du, Andy Peng Xiang, Yi Wu, Songxu Peng and Shi Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Bioresource Technology.

In The Last Decade

Ke Ming

58 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Ming China 19 406 332 250 227 218 61 1.4k
Pádraig Strappe Australia 33 1.2k 3.0× 539 1.6× 181 0.7× 177 0.8× 91 0.4× 116 2.9k
Durdi Qujeq Iran 27 777 1.9× 162 0.5× 65 0.3× 189 0.8× 36 0.2× 145 2.3k
Natividad Garrido‐Mesa Spain 24 711 1.8× 143 0.4× 25 0.1× 159 0.7× 80 0.4× 35 2.1k
Mahmoud Mahmoudi Iran 25 835 2.1× 291 0.9× 92 0.4× 88 0.4× 19 0.1× 88 2.0k
Yamei Zhang China 26 760 1.9× 316 1.0× 41 0.2× 143 0.6× 36 0.2× 134 2.2k
Parviz Kokhaei Iran 27 987 2.4× 54 0.2× 179 0.7× 198 0.9× 62 0.3× 120 2.3k
Maura Di Vito Italy 20 501 1.2× 189 0.6× 41 0.2× 69 0.3× 28 0.1× 63 1.3k
Sachiko Nomura Japan 25 426 1.0× 63 0.2× 45 0.2× 297 1.3× 45 0.2× 82 1.8k

Countries citing papers authored by Ke Ming

Since Specialization
Citations

This map shows the geographic impact of Ke Ming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Ming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Ming more than expected).

Fields of papers citing papers by Ke Ming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Ming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Ming. The network helps show where Ke Ming may publish in the future.

Co-authorship network of co-authors of Ke Ming

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Ming. A scholar is included among the top collaborators of Ke Ming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Ming. Ke Ming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Meiting, Xiujuan Chen, Ke Ming, et al.. (2025). De novo designed mini-binders targeting glyceraldehyde-3-phosphate dehydrogenase of Streptococcus equi ssp. zooepidemicus provided partial protection in mice model of infection. International Journal of Biological Macromolecules. 307(Pt 3). 142293–142293. 1 indexed citations
2.
Wu, Yelena P., et al.. (2025). The Liver Disease-Related Hypoglycemia: An Overview of the Impact, Management Approaches, and Underlying Mechanisms. British Journal of Hospital Medicine. 86(6). 1–18. 1 indexed citations
3.
Wei, Lin, Yang Hu, Yanxia Liu, et al.. (2025). De novo design mini-binder proteins targeting the glycoproteins D to inhibit PRV replication in PK15 cells. International Journal of Biological Macromolecules. 315(Pt 1). 144403–144403. 1 indexed citations
4.
Ming, Ke, Qingsong Jiang, Yan Zhu, et al.. (2025). Dietary metal(loid)s exposure and their health risks to patients with gastric precancerous lesions and gastric cancer in Anhui Province, Eastern China. Journal of Environmental Sciences. 161. 812–821. 1 indexed citations
5.
Lu, Mingming, Shiqi Li, Xinyi Ren, et al.. (2024). Development of nanobodies specific to clumping factors A of Staphylococcus aureus by yeast surface display. International Journal of Biological Macromolecules. 259(Pt 2). 129208–129208. 3 indexed citations
6.
Ming, Ke, et al.. (2023). Development of nanobodies against Staphylococcus enterotoxin B through yeast surface display. International Journal of Biological Macromolecules. 253(Pt 2). 126822–126822. 7 indexed citations
7.
Ming, Ke, et al.. (2022). Astragalus polysaccharides alleviates lipopolysaccharides-induced inflammatory lung injury by altering intestinal microbiota in mice. Frontiers in Microbiology. 13. 1033875–1033875. 23 indexed citations
8.
Ming, Ke, et al.. (2021). Comparison of viral distribution in duck hepatitis A virus-infected duckling models established by two different methods. Research in Veterinary Science. 141. 156–163. 1 indexed citations
9.
Zhou, Ziyuan, Qing Pan, Xinchen Lv, et al.. (2020). Structural insights into the inhibition of bacterial RecA by naphthalene polysulfonated compounds. iScience. 24(1). 101952–101952. 11 indexed citations
10.
11.
Du, Hongxu, Shuaibing Zhang, Miao He, et al.. (2019). Evaluation of the Therapeutic Effect of a Flavonoid Prescription against Rabbit Hemorrhagic Disease In Vivo. BioMed Research International. 2019. 1–10. 1 indexed citations
12.
Du, Hongxu, Miao He, Wen Xiong, et al.. (2019). Assessment of the hepatocyte protective effects of gypenoside and its phosphorylated derivative against DHAV-1 infection on duck embryonic hepatocytes. BMC Veterinary Research. 15(1). 134–134. 12 indexed citations
13.
Ming, Ke, Yun Chen, Jingjing Yang, et al.. (2017). Effects of Chrysanthemum indicum polysaccharide and its phosphate on anti-duck hepatitis a virus and alleviating hepatic injury. International Journal of Biological Macromolecules. 102. 813–821. 38 indexed citations
14.
Du, Hongxu, Jingjing Yang, Ke Ming, et al.. (2017). A flavone-polysaccharide based prescription attenuates the mitochondrial dysfunction induced by duck hepatitis A virus type 1. PLoS ONE. 12(4). e0175495–e0175495. 7 indexed citations
15.
Ming, Ke, Yun Chen, Fangke Yao, et al.. (2016). Phosphorylated Codonopsis pilosula polysaccharide could inhibit the virulence of duck hepatitis A virus compared with Codonopsis pilosula polysaccharide. International Journal of Biological Macromolecules. 94(Pt A). 28–35. 62 indexed citations
16.
Yao, Fangke, Yun Chen, Ke Ming, et al.. (2016). Replication cycle of duck hepatitis A virus type 1 in duck embryonic hepatocytes. Virology. 491. 73–78. 14 indexed citations
17.
Chen, Yun, Ling Zeng, Wen Xiong, et al.. (2015). Anti-duck virus hepatitis mechanisms of Bush Sophora Root polysaccharide and its sulfate verified by intervention experiments. Virus Research. 204. 58–67. 8 indexed citations
18.
Zhou, Liwen, Xiaoyong Chen, Ke Ming, et al.. (2012). IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand. The International Journal of Biochemistry & Cell Biology. 44(8). 1305–1314. 34 indexed citations
19.
Pan, Guangdong, et al.. (2000). Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling.. PubMed. 113(1). 35–9. 74 indexed citations
20.
Ming, Ke, et al.. (2000). Cisapride provides symptomatic relief in functional dyspepsia associated with gastric myoelectrical abnormality. Alimentary Pharmacology & Therapeutics. 14(8). 1041–1047. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pádraig Strappe Breakdown of academic impact, for papers by Durdi Qujeq Breakdown of academic impact, for papers by Natividad Garrido‐Mesa Breakdown of academic impact, for papers by Mahmoud Mahmoudi Breakdown of academic impact, for papers by Yamei Zhang Breakdown of academic impact, for papers by Parviz Kokhaei Breakdown of academic impact, for papers by Maura Di Vito Breakdown of academic impact, for papers by Sachiko Nomura
Rankless by CCL
2026